232 related articles for article (PubMed ID: 16227230)
1. Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon.
Targett-Adams P; McLauchlan J
J Gen Virol; 2005 Nov; 86(Pt 11):3075-3080. PubMed ID: 16227230
[TBL] [Abstract][Full Text] [Related]
2. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
[TBL] [Abstract][Full Text] [Related]
3. Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).
Miyamoto M; Kato T; Date T; Mizokami M; Wakita T
Intervirology; 2006; 49(1-2):37-43. PubMed ID: 16166787
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line.
Ali S; Pellerin C; Lamarre D; Kukolj G
J Virol; 2004 Jan; 78(1):491-501. PubMed ID: 14671129
[TBL] [Abstract][Full Text] [Related]
6. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.
Kato T; Date T; Miyamoto M; Furusaka A; Tokushige K; Mizokami M; Wakita T
Gastroenterology; 2003 Dec; 125(6):1808-17. PubMed ID: 14724833
[TBL] [Abstract][Full Text] [Related]
7. Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon.
Kato T; Date T; Miyamoto M; Zhao Z; Mizokami M; Wakita T
J Virol; 2005 Jan; 79(1):592-6. PubMed ID: 15596851
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
Wose Kinge CN; Espiritu C; Prabdial-Sing N; Sithebe NP; Saeed M; Rice CM
Antimicrob Agents Chemother; 2014 Sep; 58(9):5386-94. PubMed ID: 24982066
[TBL] [Abstract][Full Text] [Related]
9. Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.
Huang P; Goff DA; Huang Q; Martinez A; Xu X; Crowder S; Issakani SD; Anderson E; Sheng N; Achacoso P; Yen A; Kinsella T; Darwish IS; Kolluri R; Hong H; Qu K; Stauffer E; Goldstein E; Singh R; Payan DG; Lu HH
Antimicrob Agents Chemother; 2008 Apr; 52(4):1419-29. PubMed ID: 18227176
[TBL] [Abstract][Full Text] [Related]
10. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses.
Yi G; Wen Y; Shu C; Han Q; Konan KV; Li P; Kao CC
J Virol; 2016 Jan; 90(1):254-65. PubMed ID: 26468527
[TBL] [Abstract][Full Text] [Related]
12. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
[TBL] [Abstract][Full Text] [Related]
13. [Antiviral activities of ISG20 against hepatitis C virus].
Xu H; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):33-7. PubMed ID: 23663760
[TBL] [Abstract][Full Text] [Related]
14. Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a.
Robinson M; Yang H; Sun SC; Peng B; Tian Y; Pagratis N; Greenstein AE; Delaney WE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3099-106. PubMed ID: 20516274
[TBL] [Abstract][Full Text] [Related]
15. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
[TBL] [Abstract][Full Text] [Related]
16. Cell-free replication of the hepatitis C virus subgenomic replicon.
Ali N; Tardif KD; Siddiqui A
J Virol; 2002 Dec; 76(23):12001-7. PubMed ID: 12414942
[TBL] [Abstract][Full Text] [Related]
17. Effect of alpha interferon on the hepatitis C virus replicon.
Guo JT; Bichko VV; Seeger C
J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
[TBL] [Abstract][Full Text] [Related]
19. Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.
Yu M; Peng B; Chan K; Gong R; Yang H; Delaney W; Cheng G
Antimicrob Agents Chemother; 2014 May; 58(5):2638-46. PubMed ID: 24550344
[TBL] [Abstract][Full Text] [Related]
20. Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells.
Liang C; Rieder E; Hahm B; Jang SK; Paul A; Wimmer E
Virology; 2005 Mar; 333(1):41-53. PubMed ID: 15708591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
